By Aleesia Forni
Virginia Beach, Nov. 5 - Perrigo Co. Ltd. priced $2.3 billion of senior notes in four tranches, according to a company news release.
The company priced $500 million of 1.3% notes due 2016 and $600 million of 2.3% notes due 2018.
An $800 million tranche of 4% notes due 2023 was sold, as well as $400 million of 5.3% bonds due 2043.
Full details were not available at press time.
Proceeds will be used to fund the company's acquisition of Elan Corp.
The sale was done under Rule 144A and Regulation S.
The health care company and maker of generic and over-the-counter pharmaceuticals is based in Allegan, Mich.
| Issuer: | Perrigo Co. Ltd.
|
| Issue: | Senior notes
|
| Amount: | $2.3 billion
|
| Joint bookrunners: | Barclays, HSBC Securities (USA) Inc.
|
| Trade date: | Nov. 5
|
| Distribution: | Rule 144A, Regulation S
|
|
|
| Notes due 2016
|
| Amount: | $500 million
|
| Maturity: | 2016
|
| Coupon: | 1.3%
|
|
|
| Notes due 2018
|
| Amount: | $600 million
|
| Maturity: | 2018
|
| Coupon: | 2.3%
|
|
|
| Notes due 2023
|
| Amount: | $800 million
|
| Maturity: | 2023
|
| Coupon: | 4%
|
|
|
| Notes due 2043
|
| Amount: | $400 million
|
| Maturity: | 2043
|
| Coupon: | 5.3%
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
